Predictors of weight loss during conformal radiotherapy for head and neck cancers - How important are planning target volumes?

Clinical Oncology

Volumn 25, Issue 9, 2013, Pages 557-563

  Mallick, I ^a   Gupta, S K ^a   Ray, R ^a   Sinha, T ^a   Sinha, S ^a   Achari, R ^a   Chatterjee, S ^a  

^a Tata Medical Centre   (India)

Author keywords

Chemoradiation; Enteral nutrition; Head and neck cancer; PTV; Radiotherapy; Weight loss

Indexed keywords

CISPLATIN;

ADULT; ARTICLE; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; DIET SUPPLEMENTATION; FEMALE; HEAD AND NECK CANCER; HOSPITAL ADMISSION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; NASOGASTRIC TUBE; NUTRITIONAL ASSESSMENT; NUTRITIONAL COUNSELING; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TREATMENT INDICATION; TREATMENT PLANNING; WEIGHT CHANGE; WEIGHT REDUCTION;

CHEMORADIATION; ENTERAL NUTRITION; HEAD AND NECK CANCER; PTV; RADIOTHERAPY; WEIGHT LOSS;

FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84881554313     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.04.003     Document Type: Article

References (19)

1. van den Berg M.G., Rasmussen-Conrad E.L., Gwasara G.M., et al. Aprospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation. Clin Nutr 2006, 25:765-772.
2. Lavertu P., Adelstein D.J., Saxton J.P., et al. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: an 8-year single-institution experience. Arch Otolaryngol Head Neck Surg 1999, 125:142-148.
3. Bieri S., Bentzen S.M., Huguenin P., et al. Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Experience from four nonrandomized studies. Strahlenther Onkol 2003, 179:390-395.
4. Clavel S., Fortin B., Despres P., et al. Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach. Int J Radiat Oncol Biol Phys 2011, 79:763-769.
5. Capuano G., Grosso A., Gentile P.C., et al. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck 2008, 30:503-508.
6. Dawson E.R., Morley S.E., Robertson A.G., Soutar D.S. Increasing dietary supervision can reduce weight loss in oral cancer patients. Nutr Cancer 2001, 41:70-74.
7. van den Berg M.G., Rasmussen-Conrad E.L., Wei K.H., et al. Comparison of the effect of individual dietary counselling and of standard nutritional care on weight loss in patients with head and neck cancer undergoing radiotherapy. Br J Nutr 2010, 104:872-877.
8. Lee J.H., Machtay M., Unger L.D., et al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998, 124:871-875.
9. Rutter C.E., Yovino S., Taylor R., et al. Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive chemoradiation therapy. Head Neck 2011, 33:1441-1447.
10. Chen A.M., Li B.Q., Lau D.H., et al. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2010, 78:1026-1032.
11. Williams G.F., Teo M.T., Sen M., et al. Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: a role for a prophylactic gastrostomy?. Oral Oncol 2012, 48:434-440.
12. Beaver M.E., Matheny K.E., Roberts D.B., Myers J.N. Predictors of weight loss during radiation therapy. Otolaryngol Head Neck Surg 2001, 125:645-648.
13. Munshi A., Pandey M.B., Durga T., et al. Weight loss during radiotherapy for head and neck malignancies: what factors impact it?. Nutr Cancer 2003, 47:136-140.
14. Langius J.A., Doornaert P., Spreeuwenberg M.D., et al. Radiotherapy on the neck nodes predicts severe weight loss in patients with early stage laryngeal cancer. Radiother Oncol 2010, 97:80-85.
15. Nourissat A., Bairati I., Fortin A., et al. Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer. Support Care Cancer 2012, 20:591-599.
16. Gregoire V., Coche E., Cosnard G., Hamoir M., Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 2000, 56:135-150.
17. Chatterjee S., Willis N., Locks S.M., Mott J.H., Kelly C.G. Dosimetric and radiobiological comparison of helical tomotherapy, forward-planned intensity-modulated radiotherapy and two-phase conformal plans for radical radiotherapy treatment of head and neck squamous cell carcinomas. Br J Radiol 2011, 84:1083-1090.
18. Kumar S., Pandey M., Lal P., et al. Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial. Radiother Oncol 2005, 75:186-192.
19. Koiwai K., Shikama N., Sasaki S., Shinoda A., Kadoya M. Risk factors for severe dysphagia after concurrent chemoradiotherapy for head and neck cancers. Jpn J Clin Oncol 2009, 39:413-417.